Literature DB >> 14564682

Risk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complications.

K Goya1, T Kitamura, M Inaba, M Otsuki, H Yamamoto, S Kurebayashi, S Sumitani, H Saito, H Kouhara, S Kasayama, I Kawase.   

Abstract

Atherosclerotic vascular diseases are frequently associated with diabetes mellitus. There has been increasing evidence showing that the atherosclerotic diseases in diabetic patients are distinct from diabetic microvascular complications as to their pathophysiology and epidemiology. However, we have no information on the prevalence of asymptomatic atherosclerosis in diabetic patients before the onset of microvascular diseases. In the present investigation, we aimed to evaluate risk factors for the atherosclerosis in type 2 diabetic patients without the microvascular diseases. For this purpose, we evaluated atherosclerotic change of carotid arteries in 125 Japanese type 2 diabetic patients who had neither atherosclerotic vascular diseases nor diabetic microvascular complications. When atherosclerotic change was defined as the mean intima-media thickness (IMT) of >/= 1.1 mm and/or the presence of plaque lesion, 50% of patients had atherosclerosis of the carotid arteries. Risk factors for the carotid atherosclerosis were age, low-density lipoprotein (LDL)-cholesterol, hypertension, and diabetes treatment. Age and LDL-cholesterol were associated with mean IMT. Age, diabetes treatment, LDL-cholesterol, and hypertension were positively associated with plaque lesion, while high-density lipoprotein (HDL)-cholesterol was negatively associated with it. Fasting plasma glucose, glycosylated hemoglobin (HbA(1c)), and known diabetes duration remained unassociated with any parameters of asymptomatic atherosclerosis of the carotid arteries. These results indicate that glycemic control is unrelated with asymptomatic atherosclerosis in type 2 diabetic patients without diabetic microvascular complications. Conventional risk factors and diabetes treatment are independently associated with atherosclerosis of the carotid arteries in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564682     DOI: 10.1016/s0026-0495(03)00197-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

Review 1.  Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.

Authors:  Michio Otsuki; Kayoko Goya; Soji Kasayama
Journal:  Vasc Health Risk Manag       Date:  2005

2.  Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes.

Authors:  Mei-Fang Li; Yin-Fang Tu; Lian-Xi Li; Jun-Xi Lu; Xue-Hong Dong; Li-Bo Yu; Rong Zhang; Yu-Qian Bao; Wei-Ping Jia; Ren-Ming Hu
Journal:  Cardiovasc Diabetol       Date:  2013-07-24       Impact factor: 9.951

3.  Association between carotid intima-media thickness and fasting blood glucose level: A population-based cross-sectional study among low-income adults in rural China.

Authors:  Liu Gao; Lingling Bai; Min Shi; Jingxian Ni; Hongyan Lu; Yanan Wu; Jun Tu; Xianjia Ning; Jinghua Wang; Yukun Li
Journal:  J Diabetes Investig       Date:  2017-03-22       Impact factor: 4.232

4.  Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: the KORA F4 study.

Authors:  Bernd Kowall; Nina Ebert; Cornelia Then; Joachim Thiery; Wolfgang Koenig; Christa Meisinger; Wolfgang Rathmann; Jochen Seissler
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

5.  The association between elevated fasting plasma glucose levels and carotid intima-media thickness in non-diabetic adults: a population-based cross-sectional study.

Authors:  Yalin Guan; Changshen Yu; Min Shi; Jingxian Ni; Yanan Wu; Hongfei Gu; Lingling Bai; Jie Liu; Jun Tu; Jinghua Wang; Xianjia Ning
Journal:  Oncotarget       Date:  2017-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.